Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea

NCT05944965 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

OSA

Interventions

DRUG: Atomoxetine 80 mg plus Oxybutynin 5 mg
DRUG: Atomoxetine 80 MG
DRUG: Placebo

Sponsor

Brigham and Women's Hospital